Back
Extendicare 10K Form
Buy
89
EXE.TO
Extendicare
Last Price:
10.64
Seasonality Move:
5.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EXE.TO News And Ratings
See the #1 stock for the next 7 days that we like better than EXE.TO
EXE.TO Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $32.83M |
| Price / Cash Flow: | 10.86 |
| Annual Sales: | $1.36 |
| Price / Book: | 7.81 |
Profitability
| EPS (TTM): | 0.73000 |
|---|---|
| Net Income (TTM): | $63.9M |
| Gross Margin: | $135.82M |
| Return on Equity: | 64.65% |
| Return on Assets: | 9.14% |
Extendicare Earnings Forecast
Key Extendicare Financial Ratios
- The Gross Profit Margin over the past 13 years for EXE.TO is 12.38%.
- The Selling, General & Administrative Expenses for EXE.TO have been equal to 83.42% of Gross Profit Margin.
- The Interest Expense is 63.57% of Operating Income.
- The Net Earning history of EXE.TO is 2.60% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 12 years.
Extendicare Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | TSX |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | EXE.TO |
| Website: | extendicare.com |
Debt
| Debt-to-Equity Ratio: | 2.83 |
|---|---|
| Current Ratio: | 0.62 |
| Quick Ratio: | 0.57 |
Price-to-Earnings
| Trailing P/E Ratio: | 26.6 |
|---|---|
| Forward P/E Ratio: | 15.42 |
EXE.TO Technical Analysis vs Fundamental Analysis
Buy
89
Extendicare (EXE.TO)
is a Buy
Is Extendicare a Buy or a Sell?
-
Extendicare stock is rated a Buy
The current Extendicare [EXE.TO] share price is $10.64. The Score for EXE.TO is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.